Drug Designing and Development: Emerging Role of Health Technology Assessment

Anil Vaidya1,2* 1Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands 2O-Zone Health Economics and Outcomes Research Consultancy, Maastricht, The Netherlands *Corresponding author: Anil Vaidya, Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands, Tel: +31 (0)43 38 81711; E-mail: anil.vaidya@mumc.nl